Skip to content

Preoperative Fasting Duration and Gastric Residue in Pediatric Upper Gastrointestinal Endoscopy

Evaluation of Preoperative Fasting Duration and Gastric Residue in Children Undergoing Upper Gastrointestinal Endoscopy for Gastrointestinal Symptoms or Pathology

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07614919
Enrollment
110
Registered
2026-05-29
Start date
2026-06-01
Completion date
2026-07-01
Last updated
2026-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Residue, Preoperative Fasting, Upper Gastrointestinal Endoscopy

Keywords

Fasting, Endoscopy, Gastrointestinal, Gastric Emptying, Pediatrics, Anesthesia

Brief summary

This retrospective observational study aims to evaluate the relationship between preoperative fasting duration and gastric residue in pediatric patients undergoing upper gastrointestinal endoscopy for gastrointestinal symptoms or pathology. The study will assess the associations between gastric residue, gastrointestinal symptoms, underlying gastrointestinal diseases, and endoscopic findings. Data will be retrospectively collected from hospital records, anesthesia records, and endoscopy reports to investigate whether prolonged fasting duration reliably predicts an empty stomach in pediatric gastrointestinal patients.

Detailed description

Pulmonary aspiration is one of the most feared complications in pediatric anesthesia, and preoperative fasting is routinely used to reduce gastric content and aspiration risk. Current pediatric fasting guidelines support more liberal fasting regimens, especially for clear liquids, in order to avoid unnecessary prolonged fasting. However, prolonged fasting duration does not always guarantee an empty stomach, particularly in pediatric patients with gastrointestinal symptoms or underlying gastrointestinal pathology. Recent studies evaluating gastric contents in children have mainly focused on gastric ultrasonography and estimated gastric volume in healthy pediatric populations. Data regarding directly observed gastric residue during upper gastrointestinal endoscopy in pediatric gastrointestinal patients remain limited. This retrospective observational single-center study will include pediatric patients who underwent upper gastrointestinal endoscopy for gastrointestinal symptoms or pathology between January 2025 and April 2026. Data will be retrospectively obtained from hospital information systems, anesthesia records, electronic medical records, and endoscopy reports. Demographic characteristics, gastrointestinal symptoms, underlying gastrointestinal diseases, medication use, endoscopic findings, preoperative fasting duration, and endoscopically observed gastric residue will be evaluated. Gastric residue severity will be categorized as none, mild, moderate, or severe. In addition, clinically relevant residue will be defined as moderate or severe gastric residue. The primary objective of the study is to evaluate the relationship between preoperative fasting duration and gastric residue severity. Secondary analyses will assess factors associated with clinically relevant gastric residue, including gastrointestinal inflammatory disease and other clinical variables. The findings of this study may contribute to a better understanding of gastric residue patterns in pediatric gastrointestinal patients and support more individualized perioperative fasting assessment approaches.

Interventions

PROCEDUREUpper Gastrointestinal Endoscopy

Upper gastrointestinal endoscopy performed for evaluation of gastrointestinal symptoms or pathology in pediatric patients. The procedure was conducted under sedation or anesthesia according to institutional clinical practice. Endoscopic findings and endoscopically observed gastric residue were retrospectively evaluated from medical records and endoscopy reports.

Sponsors

Bursa Sevket Yilmaz Training and Research Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Pediatric patients aged under 18 years * Patients who underwent upper gastrointestinal endoscopy for gastrointestinal symptoms or pathology * Patients with available hospital records, anesthesia records, and endoscopy reports * Patients with documented preoperative fasting duration * Patients with documented endoscopic assessment of gastric residue

Exclusion criteria

* Patients aged 18 years or older * Patients with missing or incomplete data for key study variables * Patients without documented preoperative fasting duration * Patients without documented gastric residue assessment during endoscopy * Duplicate endoscopy records from the same patient, if only the first eligible procedure is included

Design outcomes

Primary

MeasureTime frameDescription
Gastric Residue SeverityAt the time of upper gastrointestinal endoscopySeverity of endoscopically observed gastric residue during upper gastrointestinal endoscopy, categorized as none, mild, moderate, or severe according to endoscopic findings documented in medical records and endoscopy reports.

Secondary

MeasureTime frameDescription
Clinically Relevant Gastric ResidueAt the time of upper gastrointestinal endoscopyPresence of clinically relevant gastric residue during upper gastrointestinal endoscopy, defined as moderate or severe gastric residue based on endoscopic observation documented in medical and endoscopy records.

Countries

Turkey (Türkiye)

Contacts

CONTACTGürcan Güler
gurcanguler.45@gmail.com+90 541 975 0407

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 30, 2026